Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-10

Clinical Trial Update: Prevention of Rabies With Four Doses of Rabies Vaccine [Phase 3]

View source ↗

Summary

An ongoing Phase 3 clinical trial evaluating a four-dose rabies vaccine regimen for prevention of rabies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rabies vaccine (four-dose regimen) (rabies vaccine)

Snippet

Sponsor: Changchun Zhuoyi Biological Co., Ltd | Conditions: Rabies Human, Antibody | Phase 3 | Status: ENROLLING_BY_INVITATION